Vitality Watch

Dossier pubmed preclinical 24-aug-2026
Animal model, organoid, or cell-culture result — not yet human

Form and function of actin impacts actin health and aging.

Key claim: Genetic or pharmacologic disruption of actin and key actin-binding proteins shortens lifespan and worsens multiple aging hallmarks in a model organism, while mild actin stabilization with jasplakinolide modestly extends lifespan, and human ACTN3 polymorphisms correlate with age-related gait-speed decline.

Abstract

The actin cytoskeleton is a fundamental and highly conserved structure that functions in diverse cellular processes, yet its direct contribution to organismal aging remains unclear. Here, we systematically interrogated how genetic and pharmacologic perturbations of actin structure and function influence lifespan and various hallmarks of aging in. Whole-animal and tissue-specific knockdown of actin and key actin-binding proteins (ABPs)-(Arp2/3),(cofilin), and(tropomyosin)-led to premature disruption of filament organization, reduced lifespan, and tissue-specific physiological defects. Actin dysfunction also displayed a more “aged” transcriptome using previously validated transcriptomics clocks, and broadly exacerbated many age-associated phenotypes, including mitochondrial dysfunction, lipid dysregulation, loss of proteostasis, impaired autophagy, and intestinal barrier failure. Pharmacological destabilization with Latrunculin A mirrored genetic knockdowns, while mild stabilization with Jasplakinolide modestly extended lifespan, emphasizing that optimal and finely tuned actin function is critical for healthy aging. Finally, analysis of human genome-wide association data revealed that commonpolymorphisms correlate with differences in age-related decline in gait speed, suggesting some links between aging and actin across organisms. Taken together, our results provide a comprehensive and publicly accessible resource that maps, for the first time, how changes in actin integrity correlate with diverse aging phenotypes across tissues. This descriptive framework is intended to enable future mechanistic discovery by offering a deep, unbiased dataset that can be integrated with emerging studies to define how actin dynamics can potentially influence aging.

Why this matters

The actin cytoskeleton in aging has largely been a review-and-correlation topic in the vault; a systematic perturbation map plus a modest jasplakinolide lifespan gain moves it toward a testable causal axis rather than descriptive hallmark association. The added human ACTN3–gait-speed GWAS signal provides the first population-level echo of the mechanism, though translation from cytoskeletal biology in a model organism to human interventions remains speculative and untested.

Source

Link

Briefing card

Form and function of actin impacts actin health and aging.
Stage: preclinical · pubmed · 24-aug-2026

Applies to researchers evaluating cytoskeletal integrity as a candidate aging axis: perturbation evidence now exists in a model organism, but no human intervention targets actin dynamics for aging outcomes.

Genetic or pharmacologic disruption of actin and key actin-binding proteins shortens lifespan and worsens multiple aging hallmarks in a model organism, while mild actin stabilization with jasplakinolide modestly extends lifespan, and human ACTN3 polymorphisms correlate with age-related gait-speed decline.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.isci.2026.117256

build build 880 · 2bcef25 · 2026-11-18